5-Minute Market Rundown(2)
Bernie's Content(2)
Best and Worst Stocks(1)
By the Numbers(2)
Indexes and ETFs(8)
Intraday Option Activity(5)
Quantitative Analysis(2)
Stock Market News(2)
Stocks On the Move(2)
Technical Analysis(1)

10/27/2017 2:43 PM
It's been a rough week for biotech stocks, due to a handful of earnings disappointments and concerns about Amazon's (AMZN) entry into the pharmaceutical sector. As such, the SPDR S&P Biotech ETF (XB...
10/24/2017 3:51 PM
It's been a strong year for the biotech sector, with the SPDR S&P Biotech ETF (XBI) and Health Care Select Sector SPDR Fund (XLV) boasting year-to-date gains of 42% and 20%, respectively. Against this...
10/17/2017 3:34 PM
Healthcare stocks are in focus today, after Senators Lamar Alexander and Patty Murray -- a Tennessee Republican and Washington Democrat, respectively -- announced a bill to reinstate federal subsidie...
9/12/2017 3:55 PM
September is historically been a weak month for the Health Care Select Sector SPDR Fund (XLV). According to data from Schaeffer's Quantitative Analyst Chris Prybal, the fund has averaged a 1.7% loss i...
6/27/2017 1:37 PM
Biotech stocks have been hot lately, with the SPDR S&P Biotech ETF (XBI) flirting with annual highs. What's more, the exchange-traded fund (ETF) is one of the best to own in the month of July, histor...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.

Partner Center